Legal Representation
Attorney
Marsha K. Hoover
USPTO Deadlines
Next Deadline
400 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-12-08)
Due Date
December 08, 2026
Grace Period Ends
June 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 12, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 4, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Mar 12, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Mar 12, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Mar 8, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Dec 8, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 22, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 22, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 2, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 19, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 18, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 17, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 17, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 8, 2020 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 24, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 28, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 27, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 13, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 12, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 12, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 6, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 2, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 29, 2020 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Feb 27, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and medical research and development; scientific research services relating to the isolation and cultivation of human tissues and cells; analysis of human tissues and cells for medical research; cultivation of human cells for medical research; cultivation of cells for transplant taken from patients
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
040
042
044